This RSA section is an unofficial mirror, is not legal advice, and may be incomplete, outdated, or incorrectly processed.

RSA 151:33 · Hospitals, End-Stage Renal Dialysis Centers, Nursing and Other Residential Care Facilities, New Hampshire Veterans' Home, Assisted Living Residences, and Ambulatory Surgical Facilities Required to Report

151:33 Hospitals, End-Stage Renal Dialysis Centers, Nursing and Other Residential Care Facilities, New Hampshire Veterans' Home, Assisted Living Residences, and Ambulatory Surgical Facilities Required to Report. –

Copy link
I.

Any hospital licensed pursuant to this chapter shall maintain a program capable of identifying and tracking infections for the purpose of reporting under this section. Such program shall have the capacity to identify the following elements:

Copy link
(a)

The specific infectious agents or toxins and site of each infection;

Copy link
(b)

The clinical department or unit within the facility where the patient first became infected or was first diagnosed; and

Copy link
(c)

The patient's diagnoses at time of admission and any relevant specific surgical, medical, or diagnostic procedure performed during the current admission.

Copy link
II.

(a) Hospitals shall initially identify, track, and report infections to include:

Copy link
(1)

Central line related bloodstream infections;

Copy link
(2)

Catheter associated urinary tract infections; and

Copy link
(3)

Surgical wound infections.

Copy link
(b)

Hospitals shall also initially identify, track, and report process measures including coverage rates of influenza vaccination for health care personnel and patients/residents. II-a. Any ambulatory surgical facility licensed pursuant to this chapter shall maintain a program capable of identifying and tracing infections for the purpose of reporting under this section. Such program shall have the capacity to identify the following elements:

Copy link
(a)

Surgical wound infections.

Copy link
(b)

Surgical antimicrobial prophylaxis.

Copy link
(c)

Coverage rates of influenza vaccination for health care personnel. II-b. Any end-stage renal dialysis center licensed pursuant to this chapter shall maintain a program capable of identifying and tracking infections for the purpose of reporting under this section. Such program shall have the capacity to identify the following elements:

Copy link
(a)

Positive blood culture.

Copy link
(b)

Vascular access site infection.

Copy link
(c)

Intravenous antimicrobial start time.

Copy link
(d)

Coverage rates of influenza vaccination for health care personnel. II-c. Any nursing and residential care facility licensed pursuant to this chapter, the New Hampshire veterans' home established under RSA 119:1, or any assisted living residence licensed under RSA 161-J shall maintain a program capable of identifying and tracking the coverage rates of influenza vaccination for health care personnel. Nothing in this section shall be construed to mandate or require influenza vaccination for health care personnel or patients/residents.

Copy link
III.

Subsequent to the initial requirements identified in paragraphs II, II-a, or II-b, the department shall, from time to time, require the tracking and reporting of other types of infections and measures when reporting protocols are identified by the department, that occur in hospitals, end-stage renal dialysis centers, and ambulatory surgical facilities in consultation with technical advisors, which shall include the Centers for Disease Control and Prevention (CDC), Centers for Medicare and Medicaid Services (CMS) Hospital Inpatient Quality Reporting Program, and the National Quality Forum, who are regionally or nationally-recognized experts in the prevention, identification, and control of health care associated infections and the reporting of performance data. All required tracking and reporting of other types of infections and measures shall be consistent with the requirements supported by the CDC, CMS Hospital Inpatient Quality Reporting Program, or the National Quality Forum.

Copy link
IV.

The commissioner of the department shall adopt rules, pursuant to RSA 541-A, for hospital, end-stage renal dialysis center, nursing and residential care facility, the New Hampshire veterans' home, assisted living residence, and ambulatory surgical facility identification, tracking, and reporting of infections, measures, and/or coverage rates of influenza vaccinations as required in this section which shall be consistent with the recommendations of recognized centers of expertise in the identification and prevention of infections including, but not limited to the National Healthcare Safety Network and the Healthcare Infection Control Practices Advisory Committee of the Centers for Disease Control and Prevention or its successor, The Joint Commission, the Centers for Medicare and Medicaid Services, the Hospital Quality Alliance, the National Quality Forum, and the New Hampshire health care quality and safety commission under RSA 151-G.

Copy link
V.

Each hospital, end-stage renal dialysis center, nursing and residential care facility, the New Hampshire veterans' home, assisted living residence, and ambulatory surgical facility shall regularly report to the department hospital, end-stage renal dialysis center, nursing and residential care facility, the New Hampshire veterans' home, assisted living residence, and ambulatory surgical facility acquired infections and the infection data it has collected and/or coverage rates of influenza vaccinations as required in this section. Such reporting shall be done in the manner directed by the department in accordance with rules adopted pursuant to RSA 541-A. The commissioner shall establish data collection and analytical methodologies that meet accepted standards for validity and reliability. In no case shall the frequency of reporting be required to be more frequently than once every 3 months, and reports shall be submitted not more than 60 days after the close of the reporting period. Source. 2006, 292:1, eff. July 1, 2007. 2009, 225:1, eff. Jan. 1, 2010. 2010, 77:2-4, eff. July 1, 2011. 2016, 192:1, eff. Aug. 2, 2016. 2021, 79:1, 2, eff. Aug. 17, 2021.

Copy link

Source note

Source. 2006, 292:1, eff. July 1, 2007. 2009, 225:1, eff. Jan. 1, 2010. 2010, 77:2-4, eff. July 1, 2011. 2016, 192:1, eff. Aug. 2, 2016. 2021, 79:1, 2, eff. Aug. 17, 2021.

Source history

  • 2006, 292:1, eff. July 1, 2007
  • 2009, 225:1, eff. Jan. 1, 2010
  • 2010, 77:2-4, eff. July 1, 2011
  • 2016, 192:1, eff. Aug. 2, 2016
  • 2021, 79:1, 2, eff. Aug. 17, 2021

Related materials

Bill relationships

  • 2026 HB1215 amend

    als through coercive or exclusive transfer arrangements that are not clinically justified. 4 New Subdivision; Transfers from Freestanding Hospital Emergency Facilities. Amend RSA 151 by inserting after section 53 the following new subdivision: Transfers from Freestanding Hospital Emergency Facilities 151:54 Definitions. In this subdivision: I. “Freestanding hospital emergency facility” or

  • 2026 HB1292 reference · effective 2027-01-01

    to this chapter. II. Notwithstanding any provision of law to the contrary, the department of health and human services shall not take action against a facility licensed under RSA 151 based primarily on the institution's participation in the treatment or use of [an investigational] a drug, biologic, or device under this chapter. III. Notwithstanding any provision of law to the contrary, a manufac

  • 2026 HB1292-FN reference · effective 2027-01-01

    to this chapter. II. Notwithstanding any provision of law to the contrary, the department of health and human services shall not take action against a facility licensed under RSA 151 based primarily on the institution's participation in the treatment or use of [an investigational] a drug, biologic, or device under this chapter. III. Notwithstanding any provision of law to the contrary, a manufac

  • 2026 HB1321 reference

    atient to alleviate symptoms of temporary discomfort or improve temporary wellness; and III. That is not administered in a physician's office or a health facility licensed under RSA 151. 329:55 Provision of Elective Intravenous Therapy. Elective intravenous therapy may only be prescribed or ordered by a physician licensed under this chapter, a physician associate licensed under RSA 328-D acting with

  • 2026 HB1347 amend

    lth care provider networks and referrals. Be it Enacted by the Senate and House of Representatives in General Court convened: 1 New Section; Health Care Referrals. Amend RSA 151 by inserting after section 9-b the following new section: 151:9-c Health Care Referrals. I. No health care facility licensed under this chapter shall prohibit referrals from independent and outside primary care prov

  • 2026 HB1562 amend · effective 2032-01-01

    herwise paid by a third party. 4 New Section; Residential Care and Health Facility Licensing; Patients' Bill of Rights for Direct Payment and Membership-Based Facilities. Amend RSA 151 by inserting after section 21-b the following new section: 151:21-c Patients' Bill of Rights for Direct Payment and Membership-Based Facilities. The policy describing the rights and responsibilities of each patient a

  • 2026 HB1562-FN amend · effective 2032-01-01

    herwise paid by a third party. 4 New Section; Residential Care and Health Facility Licensing; Patients' Bill of Rights for Direct Payment and Membership-Based Facilities. Amend RSA 151 by inserting after section 21-b the following new section: 151:21-c Patients' Bill of Rights for Direct Payment and Membership-Based Facilities. The policy describing the rights and responsibilities of each patient a

  • 2026 HB1653 amend

    protect patient safety, continuity of care, and community access. 2 New Subdivision; Patient Choice and Transfer Practices at Freestanding Hospital Emergency Facilities. Amend RSA 151 by inserting after section 53 the following new subdivision: Patient Choice and Transfer Practices at Freestanding Hospital Emergency Facilities 151:54 Definitions. In this subdivision: I. “Freestanding hospit

  • 2026 HB1660 reference · effective 2037-04-01

    ing communities compliant with 42 U.S.C. Section 3607(b); (b) Continuing care retirement communities under RSA 420-D; (c) Skilled care or nursing facilities licensed under RSA 151; (d) Assisted living facilities under RSA 151; (e) Workforce housing as defined in RSA 674:58, or (f) Other housing that addresses documented community housing needs as identified in a municipal master plan,

  • 2026 HB1735 reference

    to this chapter. II. Notwithstanding any provision of law to the contrary, the department of health and human services shall not take action against a facility licensed under RSA 151 based primarily on the institution's participation in the treatment or use of [an investigational] a drug, biologic, or device under this chapter. III. Notwithstanding any provision of law to the contrary, a manufac

  • 2026 HB1735-FN reference

    to this chapter. II. Notwithstanding any provision of law to the contrary, the department of health and human services shall not take action against a facility licensed under RSA 151 based primarily on the institution's participation in the treatment or use of [an investigational] a drug, biologic, or device under this chapter. III. Notwithstanding any provision of law to the contrary, a manufac

  • 2026 HB232 amend · effective 2027-01-01

    medical professionals. Be it Enacted by the Senate and House of Representatives in General Court convened: 1 New Subdivision; Request for Reasonable Accommodation Not to Participate in Abortion Services. Amend RSA 151 by inserting after section 53 the following new subdivision: Request for Reasonable Accommodation Not to Participate in Abortion Services 151:54 Request for Reasonable Accommodation Not to Participate in Abort